WORKFLOW-K

IDT

xGen™ Normalase™ NGS Module

xGen™ Normalase™ NGS Module
Revolutionary normalization technology for NGS libraries

This fast and automatable workflow improves cluster density and library balance and can easily be integrated into your standard DNA and RNA library preparation protocols for research studies to increase efficiency and reduce cost for NGS research laboratories.

xGen™ NGS—made to streamline.

 

IDT termékek szállítási költségei 2024.04.-től:

A szintézis helyétől, valamint a szállítási körülményektől függően az alábbi költségek kerülnek felszámításra:

  • Belgiumból: nettó 6 900 Ft

    USA-ból: nettó 34 000 Ft

    Belgiumból, szárazjégen: nettó 37 000 Ft

    USA-ból, szárazjégen: nettó 45 000 Ft

  • Oldatok szállítási költsége: mennyiség és súly függvénye, kérjen ajánlatot a Bio-Science Kft.-től!

Általános tájékoztató az IDT USA gyártási központjából érkező „custom” termékcsoportokról:

szintetikus biológiai termékek:

  • Gének
  • gBlocks, eBlocks
  • Ultramerek
  • RNS-oligók
  • CRISPR guide RNS-ek
  • oPools

qPCR próbák:

a szintézis helye a szekvencia komplexitásától, valamint a választott festék/ quencher kombinációtól függ

szolgáltatások:

  • PAGE tisztított termékek

stock termékek:

nem áll teljes lista rendelkezésre, kérjen ajánlatot a Bio-Science Kft.-től!

 

 

The xGen Normalase  Module offers a novel enzymatic library normalization technology that consolidates DNA or RNA library normalization and pooling for loading on Illumina® systems in research studies. The Normalase workflow eliminates the need for library concentration adjustment prior to library pooling, improving cluster density and library balance.

The xGen normalization method can easily be integrated into standard library preparation protocols to improve turnaround time and loading accuracy for NGS laboratories. The library selection and enzymatic normalization steps of the Normalase workflow (Figure 1) are designed for research workflows that consistently produce amplified library yields 3x the target normalization amount following library amplification with Normalase primers. For example,  ≥6 nM or ≥12 nM yield in 20 μl volume achieves 2 nM or 4 nM normalized library yield; a ≥6 nM normalization workflow will result in a 2 nM final normalized library pool, which can be concentrated to achieve 4 nM. 

This workflow does not introduce a second PCR; instead, it replaces the primers in conventional library amplification, either terminal or indexing. The xGen Normalase Kits offer a fast, scalable library normalization workflow for high-throughput research laboratories.

Normalase research workflow.

Figure 1. Normalase research workflow. The xGen Normalase research workflow begins after NGS library adapter ligation, using either full-length indexed adapters or truncated adapters, where Normalase PCR primers are used to amplify the libraries to above the minimum threshold and condition the libraries for downstream Normalase enzymology. For full-length indexed adapter libraries, xGen Normalase terminal primers are used; for truncated adapter libraries, xGen Combinatorial Dual Indexing Normalase primers are used. Amplified and conditioned NGS libraries are then individually incubated for 15 minutes with the Normalase I Master Mix to enzymatically select a specified molarity of each NGS library. After Normalase I, each library is pooled using equal volumes into a single tube and incubated for 15 minutes with the Normalase II Master Mix which enzymatically normalizes each NGS library to the specified selected molarity. The result of Normalase is a balanced, multiplexed NGS library pool ready for sequencing.

** ≥6 nM normalization workflow will result in a 2 nM final normalized library pool, which can be concentrated to achieve 4 nM. **

 

For research use only. Not for use in diagnostic procedures. Unless otherwise agreed to in writing, IDT does not intend for these products to be used in clinical applications and does not warrant their fitness or suitability for any clinical diagnostic use. Purchaser is solely responsible for all decisions regarding the use of these products and any associated regulatory or legal obligations.